Dacogen™ (Decitabine) Injection Data Presented at American Society of Hematology (ASH) Annual Meeting

Dacogen™ (Decitabine) Injection Data Presented at American Society of Hematology (ASH) Annual Meeting

Astex Announces New Licensing and Drug Discovery Alliance to Develop Novel Cell Cycle Cancer Drugs

Astex Announces New Licensing and Drug Discovery Alliance to Develop Novel Cell Cycle Cancer Drugs

MGI PHARMA and SuperGen Provide Regulatory Status Updates for Dacogen™ (decitabine) Injection for MDS

MGI PHARMA and SuperGen Provide Regulatory Status Updates for Dacogen™ (decitabine) Injection for MDS

Approvable Letter Received from the FDA for Dacogen™ (Decitabine) Injection for the Treatment of MDS

Approvable Letter Received from the FDA for Dacogen™ (Decitabine) Injection for the Treatment of MDS

Astex announces Clinical Trial Authorization for novel cancer drug AT7519 and plans for two further new drug filings in the next nine months

Astex announces Clinical Trial Authorization for novel cancer drug AT7519 and plans for two further new drug filings in the next nine months